Omers Private Equity has signed an agreement to acquire 25% stake in International Schools Partnership (“ISP” or “the Company”), a leading international group of K-12 schools from Partners Group, a leading global private markets firm. The transaction values ISP at an enterprise value of EUR 1.9bn. Partners Group will continue to hold a majority stake […]
Walder Wyss acted as legal counsel to Renaissance PME fondation suisse de placement and the minority shareholders in the sale of all the shares in JLS Digital to Swisscom. JLS is one of the leading
Homburger acted as legal counsel to Kimberly-Clark on the completion of the sale of its subsidiary Kimberly-Clark, including its paper mill in Niederbipp (Canton of Berne) as well as the «Tela» brand, to an entity
Nestlé Health Science have entered into an agreement with Nuun, a leader in functional hydration, in which Nestlé Health Science will acquire Nuun. The acquisition complements Nestlé Health Science’s existing broad portfolio of active
A team of CMS Switzerland and CMS Italy led by Stefan Brunnschweiler advised Nahrin on all legal aspects of the acquisition of the Italy based Swisscare from Alcedo IV and the two founding shareholders Stelvio
The Switzerland-based glass manufacturer Glas Troesch Holding has agreed to acquire technical glass division of Berliner Glas KGaA Herbert Kubatz GmbH & Co, from ASML Holding NV, for an undisclosed consideration. The transaction includes Schwä
Schellenberg Wittmer advised Implenia, Switzerland’s construction and real estate service provider, on the acquisition of BAM Swiss from Dutch Royal BAM Group. With this acquisition – according to a press note – Implenia has strengthened its
Niederer Kraft Frey (NKF) advised former Swiss national football player and entrepreneur David Degen on the acquisition of a majority of the shares in FC Basel Holding from Bernhard Burgener. FC Basel Holding owns 75 percent
Bär & Karrer advised Deutsche Börse in the acquisition of the remaining 49% stake in Clearstream Fund Center from UBS, advised Baker McKenzie, for CHF 390 million. Following the acquisition Deutsche Börse becomes the
The US Law firm Davis Polk advised Roivant Sciences on its combination with Montes Archimedes Acquisition Corporation, a special purchase acquisition company sponsored by Patient Square Capital, advised by Kirkland & Ellis. Roivant is expected
